EcoDrugPlus

Thymidylate Synthase

Ensembl ID : ENSMAUG00000007623
Gene Symbol: TYMS
1 Cross references
221 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMAUG00000008673
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSMAUG00000009912
Gene Symbol: TRHR
1 Cross references
266 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMAUG00000001049
Gene Symbol: TLR2
3 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSMAUG00000017099
Gene Symbol: TLR4
4 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSMAUG00000017692
Gene Symbol: TLR7
4 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSMAUG00000004487
Gene Symbol: TLR8
4 Cross references
200 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSMAUG00000017446
Gene Symbol: TLR9
4 Cross references
82 Possible Orthologues:

Topoisomerase (Dna) Ii Alpha

Ensembl ID : ENSMAUG00000010103
Gene Symbol: TOP2A
1 Cross references
209 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMAUG00000007196
Gene Symbol: TAAR1
4 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSMAUG00000013435
Gene Symbol: TGFBR1
4 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSMAUG00000008181
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).